« Previous Next » American Heart Journal
Volume 155, Issue 6 , Pages 1081-1089 , June 2008

Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention

Giuseppe G.L. Biondi-Zoccai, MD
- Division of Cardiology, University of Turin, Turin, Italy
- Reprint requests: Giuseppe Biondi-Zoccai, MD, Interventional Cardiology, Division of Cardiology, University of Turin, S. Giovanni Battista “Molinette” Hospital, Corso Bramante 88-90, 10126 Turin, Italy.
- Dr Biondi-Zoccai has consulted for Boston Scientific (Genoa, Italy), Cordis (Milan, Italy), Invatec, and Mediolanum Cardio Research (Milan, Italy), and has received lecture fees from Bristol Myers Squibb (Rome, Italy). This work is part of a senior investigator project for the Meta-analysis and Evidence-based Medicine Training in Cardiology (METCARDIO) Group, based in Turin, Italy (Protocol #4-2007 at http://www.metcardio.org/protocols.html).
- Both authors equally contributed to this work.
Marzia Lotrionte, MD
- Institute of Cardiology, Catholic University, Rome, Italy
- Both authors equally contributed to this work.
Matteo Anselmino, MD
- Division of Cardiology, University of Turin, Turin, Italy
Claudio Moretti, MD
- Division of Cardiology, University of Turin, Turin, Italy
Pierfrancesco Agostoni, MD
- Antwerp Cardiovascular Institute Middelheim, AZ Middelheim, Antwerp, Belgium
Luca Testa, MD
- Institute of Cardiology, Catholic University, Rome, Italy
Antonio Abbate, MD
- Virginia Commonwealth University Pauley Heart Center, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA
John Cosgrave, MD
- Midland Regional Hospital Mullingar, Mullingar, Ireland
Antonio Laudito, MD
- Division of Cardiac Surgery, University of Turin, Turin, Italy
Gian Paolo Trevi, MD
- Division of Cardiology, University of Turin, Turin, Italy
Imad Sheiban, MD
- Division of Cardiology, University of Turin, Turin, Italy